# Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat

> **NCT03789032** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 20 (actual)

## Conditions studied

- Drug Interaction Potentiation
- Pharmacokinetics

## Interventions

- **DRUG:** Vadadustat
- **DRUG:** Rabeprazole

## Key facts

- **NCT ID:** NCT03789032
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-03
- **Primary completion:** 2018-11-09
- **Final completion:** 2018-11-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03789032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03789032, "Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03789032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*